Medical technology company Tasso announced on Monday it has secured $2.3 million in grant funding for its HemoLink­ technology.

HemoLink is a wearable device that allows users to collect their own blood without special training.

According to a release, the source of the money came from Phase I SBIR grants, which the Madison-based company will use to demonstrate large volume sample acquisition from the capillary bed and see if HemoLink could provide better health care for underprivileged populations.

“We have compelling data, a motivated management team and an unmet clinical need in a growing market,” Tasso President Ben Moga said in a statement. “Expanding home care by enabling safe and convenient blood draws for clinical diagnosis and monitoring is exactly the kind of innovation that improves outcomes without raising healthcare costs.”